$34.00
-0.27 (-0.79%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+30.22%
YTD
-30.07%
Open$34.56
Previous Close$34.27
Day High$34.56
Day Low$33.08
52W High$56.05
52W Low$23.05
Volume—
Avg Volume3.03M
Market Cap2.46B
P/E Ratio—
EPS$-5.86
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$46.91
Below
SMA 200
$30.68
Above
RSI (14)
41.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+178.3% upside
Current
$34.00
$34.00
Target
$94.61
$94.61
$72.50
$94.61 avg
$144.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 672.08M | 640.49M | 736.20M |
| Net Income | -5,512,106 | -4,610,660 | -5,991,019 |
| Profit Margin | -0.8% | -0.7% | -0.8% |
| EBITDA | -7,633,568 | -6,751,763 | -9,172,286 |
| Free Cash Flow | -4,482,853 | -2,925,974 | -4,789,156 |
| Rev Growth | +20.0% | +11.6% | +0.9% |
| Debt/Equity | 0.79 | 0.70 | 0.90 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |